Peter Thiel Bets Big On "Mushroom Boom."
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."
Click Here To Read The Full Story

CLNN Insider Trading (Clene)

Insider Ownership Percentage: 21.20%
Insider Buying (Last 12 Months): $1,999,996.92
Insider Selling (Last 12 Months): $0.00

Clene Insider Trading History Chart

Clene Share Price & Price History

$10.79
▼ -0.52 (-4.60%)
As of 06/22/2021 02:47 PM ET
Days: 30 | 90 | 365
Peter Thiel Bets Big On "Mushroom Boom."
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."
Click Here To Read The Full Story

Clene Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/24/2021David J. MatlinDirectorBuy207,684$9.63$1,999,996.9232,393View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Clene (NASDAQ:CLNN)

4.15% of Clene stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Clene Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2021Squarepoint Ops LLC30,676$0.39M0.0%N/A0.051%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC130,068$1.66M0.0%N/A0.218%Search for SEC Filing on Google Icon
5/18/2021Morgan Stanley2,105$27K0.0%+110.5%0.004%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC46,163$0.59M0.0%N/A0.077%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC118,533$1.52M0.1%N/A0.199%Search for SEC Filing on Google Icon
5/17/2021Goldman Sachs Group Inc.13,593$0.17M0.0%N/A0.023%Search for SEC Filing on Google Icon
5/13/2021Laird Norton Trust Company LLC249,561$3.19M0.4%N/A0.419%Search for SEC Filing on Google Icon
5/13/2021Penserra Capital Management LLC5,840$74K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/13/2021Kepos Capital LP200,000$2.56M0.2%-24.0%0.336%Search for SEC Filing on Google Icon
5/13/2021Citigroup Inc.10,646$0.14M0.0%N/A0.018%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp40,246$0.51M0.0%N/A0.068%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC220,355$2.82M0.0%N/A0.370%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.54,217$0.69M0.0%N/A0.091%Search for SEC Filing on Google Icon
4/27/2021Harel Insurance Investments & Financial Services Ltd.34,911$1.49M0.0%N/A1.010%Search for SEC Filing on Google Icon
2/16/2021Walleye Trading LLC15,909$0.14M0.0%N/A0.460%Search for SEC Filing on Google Icon
2/12/2021Basso Capital Management L.P.3,239$29K0.0%N/A0.094%Search for SEC Filing on Google Icon
2/12/2021Kepos Capital LP263,235$2.37M0.2%N/A7.617%Search for SEC Filing on Google Icon
2/10/2021Bluefin Capital Management LLC15,378$0.14M0.0%N/A0.445%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean surfaced nanotechnology (CSN) therapeutics. The company has a nanotechnology drug suspension; and engages in the development and commercialization of dietary supplements. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2 study for the treatment of stable multiple sclerosis; a Phase 2 biomarker study in Parkinson's; and Phase 2 and Phase 3 trials to investigate the potential for disease modification for neurodegenerative diseases. The company's products also include CNM-AgZn17, a topical gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to accelerate wound healing; CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat disease-causing infections, such as COVID-19 and to provide immune support for symptom resolution; and CNM-PtAu7, a gold-platinum CSN therapeutic for oncology applications. Clene Inc. is headquartered in Salt Lake City, Utah.
Read More on Clene

Today's Range

Now: $10.79
$10.79
$11.31

50 Day Range

MA: $10.16
$6.98
$12.89

52 Week Range

Now: $10.79
$6.23
$16.50

Volume

3,846 shs

Average Volume

191,982 shs

Market Capitalization

$642.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.06

Who are the company insiders with the largest holdings of Clene?

Clene's top insider shareholders include:
  1. David J Matlin (Director)

Who are the major institutional investors of Clene?

Clene's top institutional shareholders include:
  1. Laird Norton Trust Company LLC — 0.42%
  2. Geode Capital Management LLC — 0.37%
  3. Kepos Capital LP — 0.34%
  4. Millennium Management LLC — 0.22%
  5. Ikarian Capital LLC — 0.20%
  6. BlackRock Inc. — 0.09%

Which institutional investors are selling Clene stock?

Within the last quarter, CLNN stock was sold by these institutional investors:
  1. Kepos Capital LP

Which institutional investors are buying Clene stock?

During the last quarter, CLNN stock was acquired by institutional investors including:
  1. Laird Norton Trust Company LLC
  2. Geode Capital Management LLC
  3. Millennium Management LLC
  4. Ikarian Capital LLC
  5. BlackRock Inc.
  6. Citadel Advisors LLC
  7. Northern Trust Corp
  8. Harel Insurance Investments & Financial Services Ltd.
Invest In Psychedelic Therapy?
Psychedelic Therapy Clinics are popping up all over LA and Arizona. Some of them charge up to $2,000 for a full treatment... this is an emerging trend every investor should consider.
Tell Me More About Psychedelic Therapy